List of Tables
Table 1. Global Parenteral Dosage Form Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Parenteral Dosage Form Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Parenteral Dosage Form Market Competitive Situation by Manufacturers in 2024
Table 4. Global Parenteral Dosage Form Sales (Kiloton) of Key Manufacturers (2020-2025)
Table 5. Global Parenteral Dosage Form Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Parenteral Dosage Form Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Parenteral Dosage Form Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Parenteral Dosage Form Average Price (US$/Ton) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Parenteral Dosage Form, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Parenteral Dosage Form, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Parenteral Dosage Form, Product Type & Application
Table 12. Global Key Manufacturers of Parenteral Dosage Form, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Parenteral Dosage Form by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parenteral Dosage Form as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Parenteral Dosage Form Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Parenteral Dosage Form Sales by Region (2020-2025) & (Kiloton)
Table 18. Global Parenteral Dosage Form Sales Market Share by Region (2020-2025)
Table 19. Global Parenteral Dosage Form Sales by Region (2026-2031) & (Kiloton)
Table 20. Global Parenteral Dosage Form Sales Market Share by Region (2026-2031)
Table 21. Global Parenteral Dosage Form Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Parenteral Dosage Form Revenue Market Share by Region (2020-2025)
Table 23. Global Parenteral Dosage Form Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Parenteral Dosage Form Revenue Market Share by Region (2026-2031)
Table 25. North America Parenteral Dosage Form Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Parenteral Dosage Form Sales by Country (2020-2025) & (Kiloton)
Table 27. North America Parenteral Dosage Form Sales by Country (2026-2031) & (Kiloton)
Table 28. North America Parenteral Dosage Form Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Parenteral Dosage Form Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Parenteral Dosage Form Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Parenteral Dosage Form Sales by Country (2020-2025) & (Kiloton)
Table 32. Europe Parenteral Dosage Form Sales by Country (2026-2031) & (Kiloton)
Table 33. Europe Parenteral Dosage Form Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Parenteral Dosage Form Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Parenteral Dosage Form Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Parenteral Dosage Form Sales by Region (2020-2025) & (Kiloton)
Table 37. Asia Pacific Parenteral Dosage Form Sales by Region (2026-2031) & (Kiloton)
Table 38. Asia Pacific Parenteral Dosage Form Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Parenteral Dosage Form Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Parenteral Dosage Form Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Parenteral Dosage Form Sales by Country (2020-2025) & (Kiloton)
Table 42. Latin America Parenteral Dosage Form Sales by Country (2026-2031) & (Kiloton)
Table 43. Latin America Parenteral Dosage Form Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Parenteral Dosage Form Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Parenteral Dosage Form Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Parenteral Dosage Form Sales by Country (2020-2025) & (Kiloton)
Table 47. Middle East and Africa Parenteral Dosage Form Sales by Country (2026-2031) & (Kiloton)
Table 48. Middle East and Africa Parenteral Dosage Form Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Parenteral Dosage Form Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Parenteral Dosage Form Sales (Kiloton) by Type (2020-2025)
Table 51. Global Parenteral Dosage Form Sales (Kiloton) by Type (2026-2031)
Table 52. Global Parenteral Dosage Form Sales Market Share by Type (2020-2025)
Table 53. Global Parenteral Dosage Form Sales Market Share by Type (2026-2031)
Table 54. Global Parenteral Dosage Form Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Parenteral Dosage Form Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Parenteral Dosage Form Revenue Market Share by Type (2020-2025)
Table 57. Global Parenteral Dosage Form Revenue Market Share by Type (2026-2031)
Table 58. Global Parenteral Dosage Form Price (US$/Ton) by Type (2020-2025)
Table 59. Global Parenteral Dosage Form Price (US$/Ton) by Type (2026-2031)
Table 60. Global Parenteral Dosage Form Sales (Kiloton) by Application (2020-2025)
Table 61. Global Parenteral Dosage Form Sales (Kiloton) by Application (2026-2031)
Table 62. Global Parenteral Dosage Form Sales Market Share by Application (2020-2025)
Table 63. Global Parenteral Dosage Form Sales Market Share by Application (2026-2031)
Table 64. Global Parenteral Dosage Form Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Parenteral Dosage Form Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Parenteral Dosage Form Revenue Market Share by Application (2020-2025)
Table 67. Global Parenteral Dosage Form Revenue Market Share by Application (2026-2031)
Table 68. Global Parenteral Dosage Form Price (US$/Ton) by Application (2020-2025)
Table 69. Global Parenteral Dosage Form Price (US$/Ton) by Application (2026-2031)
Table 70. Ashland Company Information
Table 71. Ashland Description and Business Overview
Table 72. Ashland Parenteral Dosage Form Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 73. Ashland Parenteral Dosage Form Product
Table 74. Ashland Recent Developments/Updates
Table 75. Tepnel Pharma Services Company Information
Table 76. Tepnel Pharma Services Description and Business Overview
Table 77. Tepnel Pharma Services Parenteral Dosage Form Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 78. Tepnel Pharma Services Parenteral Dosage Form Product
Table 79. Tepnel Pharma Services Recent Developments/Updates
Table 80. Ascendia Pharmaceuticals Company Information
Table 81. Ascendia Pharmaceuticals Description and Business Overview
Table 82. Ascendia Pharmaceuticals Parenteral Dosage Form Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 83. Ascendia Pharmaceuticals Parenteral Dosage Form Product
Table 84. Ascendia Pharmaceuticals Recent Developments/Updates
Table 85. Thermo Fisher Scientific Company Information
Table 86. Thermo Fisher Scientific Description and Business Overview
Table 87. Thermo Fisher Scientific Parenteral Dosage Form Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 88. Thermo Fisher Scientific Parenteral Dosage Form Product
Table 89. Thermo Fisher Scientific Recent Developments/Updates
Table 90. ProJect Pharmaceutics Company Information
Table 91. ProJect Pharmaceutics Description and Business Overview
Table 92. ProJect Pharmaceutics Parenteral Dosage Form Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 93. ProJect Pharmaceutics Parenteral Dosage Form Product
Table 94. ProJect Pharmaceutics Recent Developments/Updates
Table 95. Lonza Company Information
Table 96. Lonza Description and Business Overview
Table 97. Lonza Parenteral Dosage Form Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 98. Lonza Parenteral Dosage Form Product
Table 99. Lonza Recent Developments/Updates
Table 100. BOC Sciences Company Information
Table 101. BOC Sciences Description and Business Overview
Table 102. BOC Sciences Parenteral Dosage Form Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 103. BOC Sciences Parenteral Dosage Form Product
Table 104. BOC Sciences Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Parenteral Dosage Form Distributors List
Table 108. Parenteral Dosage Form Customers List
Table 109. Parenteral Dosage Form Market Trends
Table 110. Parenteral Dosage Form Market Drivers
Table 111. Parenteral Dosage Form Market Challenges
Table 112. Parenteral Dosage Form Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
Table 116. Authors List of This Report
List of Figures
Figure 1. Product Picture of Parenteral Dosage Form
Figure 2. Global Parenteral Dosage Form Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Parenteral Dosage Form Market Share by Type: 2024 & 2031
Figure 4. Emulsions for Injection Product Picture
Figure 5. Powders for Injection Product Picture
Figure 6. Gels for Injection Product Picture
Figure 7. Global Parenteral Dosage Form Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Parenteral Dosage Form Market Share by Application: 2024 & 2031
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Others
Figure 12. Global Parenteral Dosage Form Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Parenteral Dosage Form Market Size (2020-2031) & (US$ Million)
Figure 14. Global Parenteral Dosage Form Sales (2020-2031) & (Kiloton)
Figure 15. Global Parenteral Dosage Form Average Price (US$/Ton) & (2020-2031)
Figure 16. Parenteral Dosage Form Report Years Considered
Figure 17. Parenteral Dosage Form Sales Share by Manufacturers in 2024
Figure 18. Global Parenteral Dosage Form Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Parenteral Dosage Form Players: Market Share by Revenue in Parenteral Dosage Form in 2024
Figure 20. Parenteral Dosage Form Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Parenteral Dosage Form Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Parenteral Dosage Form Sales Market Share by Country (2020-2031)
Figure 23. North America Parenteral Dosage Form Revenue Market Share by Country (2020-2031)
Figure 24. U.S. Parenteral Dosage Form Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Parenteral Dosage Form Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Parenteral Dosage Form Sales Market Share by Country (2020-2031)
Figure 27. Europe Parenteral Dosage Form Revenue Market Share by Country (2020-2031)
Figure 28. Germany Parenteral Dosage Form Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Parenteral Dosage Form Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Parenteral Dosage Form Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Parenteral Dosage Form Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Parenteral Dosage Form Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Parenteral Dosage Form Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Parenteral Dosage Form Revenue Market Share by Region (2020-2031)
Figure 35. China Parenteral Dosage Form Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Parenteral Dosage Form Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Parenteral Dosage Form Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Parenteral Dosage Form Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Parenteral Dosage Form Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Taiwan Parenteral Dosage Form Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Indonesia Parenteral Dosage Form Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Thailand Parenteral Dosage Form Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Malaysia Parenteral Dosage Form Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Philippines Parenteral Dosage Form Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Parenteral Dosage Form Sales Market Share by Country (2020-2031)
Figure 46. Latin America Parenteral Dosage Form Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Parenteral Dosage Form Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Parenteral Dosage Form Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Parenteral Dosage Form Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Parenteral Dosage Form Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Parenteral Dosage Form Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Parenteral Dosage Form Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Parenteral Dosage Form Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. U.A.E Parenteral Dosage Form Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Parenteral Dosage Form by Type (2020-2031)
Figure 56. Global Revenue Market Share of Parenteral Dosage Form by Type (2020-2031)
Figure 57. Global Parenteral Dosage Form Price (US$/Ton) by Type (2020-2031)
Figure 58. Global Sales Market Share of Parenteral Dosage Form by Application (2020-2031)
Figure 59. Global Revenue Market Share of Parenteral Dosage Form by Application (2020-2031)
Figure 60. Global Parenteral Dosage Form Price (US$/Ton) by Application (2020-2031)
Figure 61. Parenteral Dosage Form Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
